We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Effect of Triethylenethiophosphoramide (Thio-TEPA) upon Healing of Abdominal Wounds

AMA Arch Surg. 1959;78(5):729-731. doi:10.1001/archsurg.1959.04320050061009.
Text Size: A A A
Published online


Triethylenethiophosphoramide ( thioTEPA) and mechlorethamine (nitrogen mustard) are used at the time of operation for cancer to discourage the local and distant implantation of the cancer cells in the body. If these cytotoxic drugs are capable of destroying the malignant cells, it is logical to question whether they might also affect the young and proliferating cells of a healing wound. In a previous report1 we showed experimentally that mechlorethamine interfered with the healing of wounds and reduced their tensile strength. Mechlorethamine also caused weight loss in animals (Fig. 1). We were, however, unable to determine whether reduction of tensile strength was a direct result of mechlorethamine on the healing wound or secondary to malnutrition (as manifested by loss of weight).

In the present study we have determined the effect of thio-TEPA on the healing of abdominal wounds in rats. The results suggest that thio-TEPA, in contrast with mechlorethamine, does not


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.